Halozyme Therapeutics Inc.

About Halozyme Therapeutics Inc.

Halozyme is dedicated to reinventing the patient experience by prioritizing patient needs in all aspects of their work. They focus on developing disruptive drug delivery technologies and maintaining a robust commercial portfolio to ease the burden of treatment and improve patient outcomes.

Products & Services

ENHANZE®:A drug delivery technology designed to enhance the patient experience.

Auto-Injector & Multi-Dose Pen Technologies:Innovative delivery systems for medications, aimed at improving ease of use.

Commercial Products:A portfolio of products available in the market, though specific details are not provided.

Specialties

Drug Delivery Technologies Patient Experience Improvement

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Debt T: - FT: Convertible Debt	A: 1300000000 MR: - FA: $1,300,000,000 FAN: 1300000000	D: 2025-11-06 FD: 2025-11-06	-
2	RT: Convertible Debt T: - FT: Convertible Debt	A: 1300000000 MR: - FA: $1,300,000,000 FAN: 1300000000	D: 2025-11-05 FD: 2025-11-05	-
3	RT: Accelerated Share Repurchase T: - FT: Accelerated Share Repurchase	A: 250000000 MR: - FA: $250 million FAN: 250000000	D: 2025-01-08 FD: 2025-01-08	-

Convertible Debt Latest

2025-11-06

$1.3B

Convertible Debt 2025-11-05

$1.3B

Accelerated Share Repurchase 2025-01-08

$250.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Helen Torley, M.B. Ch. B., M.R.C.P.

President and Chief Executive Officer

N

Nicole LaBrosse

Chief Financial Officer

M

Mark Snyder

Chief Legal Officer

C

Charles Theuer

Chief Medical Officer

C

Cortney Caudill

Chief Operations Officer

C

Chris Wahl, MD, MBA

Chief Business Officer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News